Home»
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.
Accès à distance ? S'identifier sur le proxy UCLouvain
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.
In the context of discussions on the reproducibility of clinical studies, we reanalyzed a prospective randomized study on the role of splenic irradiation as adjunct to the conditioning for hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML). Between 1986 and 1989, a total of 229 patients with CML were randomized; of these, 225 (98 %; 112 with, 113 without splenic irradiation) could be identified in the database and their survival updated. Results confirmed the early findings with no significant differences in all measured endpoints (overall survival at 25 years: 42.7 %, 32.0-52.4 % vs 52.9 %, 43.2-62.6 %; p = 0.355, log rank test). Additional splenic irradiation failed to reduce relapse incidence. It did not increase non-relapse mortality nor the risk of late secondary malignancies. Comforting are the long-term results from this predefined consecutive cohort of patients: more than 60 % were alive at plus 25 years when they were transplanted with a low European Society for Blood and Marrow Transplantation (EBMT) risk sore. This needs to be considered today when treatment options are discussed for patients who failed initial tyrosine kinase inhibitor therapy and have an available low risk HLA-identical donor.
GOLDMAN J, MARROW TRANSPLANTATION FOR PATIENTS IN THE CHRONIC PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA, 10.1016/s0140-6736(82)92736-2
MCGLAVE P, SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS IN THE ACCELERATED PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA, 10.1016/s0140-6736(82)92737-4
GRATWOHL A, EFFECT OF SPLENECTOMY BEFORE BONE-MARROW TRANSPLANTATION ON SURVIVAL IN CHRONIC GRANULOCYTIC LEUKAEMIA, 10.1016/s0140-6736(85)91566-1
Gratwohl A, Hermans J, von Biezen A et al (1992) No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized study. Bone Marrow Transplant 10:147–152
Gratwohl A., Hermans J., V. Biezen A., Arcese W., Debusscher L., Ernst P., Ferrant A., Frassoni F., Gahrton G., Iriondo A., Kolb H. J., Link H., Niederwieser D., Ruutu T., Schattenberg A., Schmitz N., Siegert W., Torres-Gomez A., Vernant J. P., Zwaan F. E., Apperley J., Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia, 10.1046/j.1365-2141.1996.d01-1929.x
O'Brien Stephen G., Guilhot François, Larson Richard A., Gathmann Insa, Baccarani Michele, Cervantes Francisco, Cornelissen Jan J., Fischer Thomas, Hochhaus Andreas, Hughes Timothy, Lechner Klaus, Nielsen Johan L., Rousselot Philippe, Reiffers Josy, Saglio Giuseppe, Shepherd John, Simonsson Bengt, Gratwohl Alois, Goldman John M., Kantarjian Hagop, Taylor Kerry, Verhoef Gregor, Bolton Ann E., Capdeville Renaud, Druker Brian J., Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia, 10.1056/nejmoa022457
Baccarani M., Deininger M. W., Rosti G., Hochhaus A., Soverini S., Apperley J. F., Cervantes F., Clark R. E., Cortes J. E., Guilhot F., Hjorth-Hansen H., Hughes T. P., Kantarjian H. M., Kim D.-W., Larson R. A., Lipton J. H., Mahon F.-X., Martinelli G., Mayer J., Muller M. C., Niederwieser D., Pane F., Radich J. P., Rousselot P., Saglio G., Saussele S., Schiffer C., Silver R., Simonsson B., Steegmann J.-L., Goldman J. M., Hehlmann R., European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013, 10.1182/blood-2013-05-501569
Ito Takeshi, Akagi Kentaro, Kondo Tadakazu, Kawabata Hiroshi, Ichinohe Tatsuo, Takaori-Kondo Akifumi, Splenic Irradiation as a Component of a Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Myelofibrosis with Massive Splenomegaly, 10.1620/tjem.228.295
Gratwohl A, Pfirrmann M, Zander A et al (2015) Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia. doi: 10.1038/leu.2015.281
Barrett A. J., Ito S., The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century, 10.1182/blood-2014-10-567784
Gratwohl Alois, Hematopoietic Stem Cell TransplantationA Global Perspective, 10.1001/jama.2010.491
Pasquini MC (2012) Hematopoietic cell transplantation for chronic myeloid leukemia in developing countries: perspectives from Latin America in the post-tyrosine kinase inhibitor era. Hematology 17(Suppl 1):S79–S82
Ebrahim Shanil, Sohani Zahra N., Montoya Luis, Agarwal Arnav, Thorlund Kristian, Mills Edward J., Ioannidis John P. A., Reanalyses of Randomized Clinical Trial Data, 10.1001/jama.2014.9646
Barbui T., Bjorkholm M., Gratwohl A., Optimizing investigator-led oncology research in Europe, 10.3324/haematol.2012.064873
Taylor Jayne, Patrick Hannah, Lyratzopoulos Georgios, Campbell Bruce, METHODOLOGICAL CHALLENGES IN EVALUATING THE VALUE OF REGISTERS, 10.1017/s0266462313000731
Bibliographic reference
Gratwohl, Alois ; Iacobelli, Simona ; Bootsman, Natalia ; van Biezen, Anja ; Baldomero, Helen ; et. al. Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.. In: Annals of Hematology, Vol. 95, no.6, p. 967-972 (2016)